About Us

About us

Tigermed-Jyton, a wholly-owned subsidiary of Tigermed Group (Stock code: 300347.SZ/3347.HK), was established in 2000, and is a leading CRO service provider in China for regulatory affairs and clinical research of medical devices (including in vitro diagnostic products), with service covering the whole life cycle of all fields of medical devices. In the past 20 years, we have established long-term cooperative relations with more than 1,700 medical device R&D and manufacture enterprises from more than 30 countries. With our professional service capability, we can reduce registration risk, shorten project timeline, save R&D funds and accelerate the process of product marketization.

Global Layout

Tigermed-Jyton is headquartered in Beijing. Supported by Tigermed Group, we are able to cover 138 cities in China mainland, Hong Kong and Taiwan. Globally, we have set up offices in 15 countries and regions including Korea, Japan, Malaysia, the United States and Europe, etc.

Expert Team

Tigermed-Jyton medical device innovation and development technology service platform has more than 300 experts in various fields of medical devices. The professional and innovative management team all have more than ten years of professional experience.

Learn More


The most competitive medical device CRO in China

  • 2020
    implement a global strategy for the whole life cycle of medical devices
  • 2017
    Become a subsidiary of Tigermed, 300+ employees
  • 2015
    Tigermed-Jyton Testing lab, "National High-tech Enterprise"
  • 2012
    Obtain ISO9001 certification, IVD department
  • 2010
    Hold the 1st China International Medical Device Regulatory Forum (CIMDR),100+ employees
  • 2004
    Obtain 1000+ medical device registration certificates
  • 2000
    Tigermed-Jyton foundation,the 1st medical device CRO

Company culture

Patient first 
Continue to innovate

Company Qualification

ISO9001National High-Tech Enterprise National High-Tech Enterprise

CNAS/CMA qualification testing lab